Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients.

Mishra DK, Creighton CJ, Zhang Y, Gibbons DL, Kurie JM, Kim MP.

Int J Cancer. 2014 Feb 15;134(4):789-98. doi: 10.1002/ijc.28428. Epub 2013 Sep 3.

2.

Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.

Huang Q, Fan J, Qian X, Lv Z, Zhang X, Han J, Wu F, Chen C, Du J, Guo M, Hu G, Jin Y.

J Cancer Res Clin Oncol. 2016 Jan;142(1):263-72. doi: 10.1007/s00432-015-2040-0. Epub 2015 Aug 30.

PMID:
26319393
3.
4.
5.

Ex vivo four-dimensional lung cancer model mimics metastasis.

Mishra DK, Creighton CJ, Zhang Y, Chen F, Thrall MJ, Kim MP.

Ann Thorac Surg. 2015 Apr;99(4):1149-56. doi: 10.1016/j.athoracsur.2014.08.085. Epub 2015 Feb 18.

6.

Human lung cancer cells grown in an ex vivo 3D lung model produce matrix metalloproteinases not produced in 2D culture.

Mishra DK, Sakamoto JH, Thrall MJ, Baird BN, Blackmon SH, Ferrari M, Kurie JM, Kim MP.

PLoS One. 2012;7(9):e45308. doi: 10.1371/journal.pone.0045308. Epub 2012 Sep 17.

7.

Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.

Lappi-Blanco E, Mäkinen JM, Lehtonen S, Karvonen H, Sormunen R, Laitakari K, Johnson S, Mäkitaro R, Bloigu R, Kaarteenaho R.

Tumour Biol. 2016 Oct;37(10):13811-13820. Epub 2016 Aug 1.

PMID:
27481516
8.

Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.

Bleckmann A, Siam L, Klemm F, Rietkötter E, Wegner C, Kramer F, Beissbarth T, Binder C, Stadelmann C, Pukrop T.

Clin Exp Metastasis. 2013 Apr;30(4):471-82. doi: 10.1007/s10585-012-9552-7. Epub 2012 Dec 8.

9.

PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer.

Sato T, Kaneda A, Tsuji S, Isagawa T, Yamamoto S, Fujita T, Yamanaka R, Tanaka Y, Nukiwa T, Marquez VE, Ishikawa Y, Ichinose M, Aburatani H.

Sci Rep. 2013;3:1911. doi: 10.1038/srep01911.

10.

AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.

Albertus DL, Seder CW, Chen G, Wang X, Hartojo W, Lin L, Silvers A, Thomas DG, Giordano TJ, Chang AC, Orringer MB, Bigbee WL, Chinnaiyan AM, Beer DG.

J Thorac Oncol. 2008 Nov;3(11):1236-44. doi: 10.1097/JTO.0b013e318189f5ec.

11.

Pathobiological implications of MUC4 in non-small-cell lung cancer.

Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S, Shimizu ST, West WW, Johansson SL, Smith LM, Yu F, Rolle CE, Sharma P, Carey GB, Batra SK, Ganti AK.

J Thorac Oncol. 2013 Apr;8(4):398-407. doi: 10.1097/JTO.0b013e3182829e06.

12.

Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.

Sakashita H, Inoue H, Akamine S, Ishida T, Inase N, Shirao K, Mori M, Mimori K.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S590-8. doi: 10.1245/s10434-013-3059-6. Epub 2013 Jun 28. Erratum in: Ann Surg Oncol. 2014 Dec;21 Suppl 4:S783.

PMID:
23812770
13.

MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.

Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, Korn RL, Ross JT, Dhruv H, Foss KM, Sibenaller Z, Ryken T, Gotway MB, Kim S, Weiss GJ.

Int J Cancer. 2011 Dec 1;129(11):2621-31. doi: 10.1002/ijc.25939. Epub 2011 Mar 29.

14.

Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.

Shao C, Sullivan JP, Girard L, Augustyn A, Yenerall P, Rodriguez-Canales J, Liu H, Behrens C, Shay JW, Wistuba II, Minna JD.

Clin Cancer Res. 2014 Aug 1;20(15):4154-66. doi: 10.1158/1078-0432.CCR-13-3292. Epub 2014 Jun 6.

15.

High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.

Wei LX, Zhou RS, Xu HF, Wang JY, Yuan MH.

Tumour Biol. 2013 Apr;34(2):941-6. doi: 10.1007/s13277-012-0629-3. Epub 2012 Dec 22.

PMID:
23264086
16.

Genetic determinants of pemetrexed responsiveness and nonresponsiveness in non-small cell lung cancer cells.

Wu MF, Hsiao YM, Huang CF, Huang YH, Yang WJ, Chan HW, Chang JT, Ko JL.

J Thorac Oncol. 2010 Aug;5(8):1143-51. doi: 10.1097/JTO.0b013e3181e0b954.

17.

CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.

Wuttig D, Zastrow S, Füssel S, Toma MI, Meinhardt M, Kalman K, Junker K, Sanjmyatav J, Boll K, Hackermüller J, Rolle A, Grimm MO, Wirth MP.

Int J Cancer. 2012 Sep 1;131(5):E693-704. doi: 10.1002/ijc.27419. Epub 2012 Feb 28.

18.

NRF2 regulates serine biosynthesis in non-small cell lung cancer.

DeNicola GM, Chen PH, Mullarky E, Sudderth JA, Hu Z, Wu D, Tang H, Xie Y, Asara JM, Huffman KE, Wistuba II, Minna JD, DeBerardinis RJ, Cantley LC.

Nat Genet. 2015 Dec;47(12):1475-81. doi: 10.1038/ng.3421. Epub 2015 Oct 19. Erratum in: Nat Genet. 2016 Apr;48(4):473.

19.

Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC.

Perumal D, Pillai S, Nguyen J, Schaal C, Coppola D, Chellappan SP.

Oncotarget. 2014 Nov 15;5(21):10486-502.

20.

Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue.

Frullanti E, Colombo F, Falvella FS, Galvan A, Noci S, De Cecco L, Incarbone M, Alloisio M, Santambrogio L, Nosotti M, Tosi D, Pastorino U, Dragani TA.

Int J Cancer. 2012 Sep 1;131(5):E643-8. doi: 10.1002/ijc.27426. Epub 2012 Feb 28.

Supplemental Content

Support Center